How to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice.
- Published in:
- Current Rheumatology Reports, 2024, v. 26, n. 5, p. 170, doi. 10.1007/s11926-024-01141-0
- By:
- Publication type:
- Article
Works matching IS 15233774 AND DT 2024 AND VI 26 AND IP 5
Results: 5
1
2
Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives.
- Published in:
- Current Rheumatology Reports, 2024, v. 26, n. 5, p. 178, doi. 10.1007/s11926-024-01140-1
- By:
- Publication type:
- Article
3
Effect of Osteoporosis Treatments on Osteoarthritis Progression in Postmenopausal Women: A Review of the Literature.
- Published in:
- Current Rheumatology Reports, 2024, v. 26, n. 5, p. 188, doi. 10.1007/s11926-024-01139-8
- By:
- Publication type:
- Article
4
Dose Tapering and Discontinuation of Biologic DMARDs in Axial Spondyloarthritis: A Narrative Review (2023 SPARTAN Annual Meeting Proceedings).
- Published in:
- Current Rheumatology Reports, 2024, v. 26, n. 5, p. 155, doi. 10.1007/s11926-024-01137-w
- By:
- Publication type:
- Article
5
Year in Review in Axial Spondyloarthritis Clinical Research and Guidelines: SPARTAN 2023 Annual Meeting Proceedings.
- Published in:
- Current Rheumatology Reports, 2024, v. 26, n. 5, p. 164, doi. 10.1007/s11926-024-01134-z
- By:
- Publication type:
- Article